{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is Quanterix Corp. technically bullish or bearish?
As of June 6, 2025, the market trend is mildly bearish, influenced by daily moving averages and monthly MACD signals, despite some short-term strength indicated by weekly indicators.
Who are in the management team of Quanterix Corp.?
As of March 2022, the management team of Quanterix Corp. includes E. Kevin Hrusovsky (Chairman, President, CEO), Dr. Martin Madaus (Lead Independent Director), and Independent Directors Keith Crandell, Dr. Marijn Dekkers, Sarah Hlavinka, and Paul Meister. They are responsible for the company's strategic direction and governance.
What does Quanterix Corp. do?
Quanterix Corp. develops ultra-sensitive digital immunoassay platforms for life science research and diagnostics in the Pharmaceuticals & Biotechnology industry. As of March 2025, it reported net sales of $30 million and a net loss of $21 million, with a market cap of $238.57 million.
How big is Quanterix Corp.?
As of Jun 18, Quanterix Corp. has a market capitalization of 238.57 million and reported net sales of 135.68 million with a net profit of -47.87 million over the latest four quarters. Shareholder's funds are at 330.04 million, with total assets of 411.74 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
